Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke

Area of Science:

• Regenerative Medicine
• Neuroscience
• Biomedical Engineering

Background:

• Global population aging increases stroke prevalence and socioeconomic burden.
• Stroke treatment and research are critical scientific challenges.
• Stem cell transplantation, particularly Mesenchymal Stem Cells (MSCs), offers therapeutic potential for neurodegenerative diseases, including stroke.

Purpose of the Study:

• To review the therapeutic mechanisms of MSCs and their secreted extracellular vesicles (EVs) for stroke.
• To elucidate how MSCs and EVs attenuate inflammation, promote repair, and enhance recovery post-stroke.

Main Methods:

• Review of existing literature on stem cell therapy for stroke.
• Analysis of MSCs and EVs' roles in immunomodulation, trophic factor release, angiogenesis, and neurogenesis.
• Examination of MSCs' potential for cell replacement in damaged brain tissue.

Main Results:

• MSCs and EVs demonstrate multifaceted therapeutic effects in preclinical and clinical stroke studies.
• Key mechanisms include reducing inflammation via immunomodulation and releasing beneficial trophic factors.
• Promotion of angiogenesis, neurogenesis, and reduction of infarct volume are observed.

Conclusions:

• Mesenchymal stem cells (MSCs) and extracellular vesicles (EVs) represent a promising therapeutic strategy for stroke.
• Their ability to modulate the inflammatory response and promote endogenous repair mechanisms is crucial.
• Further research into MSC and EV therapy can lead to improved outcomes for stroke patients.